Demystifying the Digital Therapeutics Ecosystem
Hosted by: Ross Muken, Partner & Senior Managing Director, Evercore ISI
October 30, 2019: 12:00 – 2:00pm
Healthcare has been slow to incorporate technology into the clinical continuum. An increasingly complex regulatory environment, misaligned incentives across key industry participants, mixed early attempts on basic health/well-being, and harnessing ‘Big Data’ in a population setting have stymied progress. Fortunately, a new wave of highly innovative companies has sprung up with the aim of merging technology with evidence-based medicine, offering the potential to finally fulfill the promise of enhancing patient care and revolutionizing the treatment paradigm for major disease conditions.
Ross Muken, a leading healthcare equity analyst at Evercore ISI, will offer a series of panels aimed at demystifying this new class of technology-driven disruptors. Content will appeal to a broad audience, including payers, pharma/device partners, benefit managers, growth investors, and industry technologists.
Topics covered include:
- The Influence of AI + Big Data Disruption Across Drug Discovery
- Opportunities for Partnership Across the Digital Therapy Continuum
- Going Beyond Behavioral Health to New Modalities
- Reimbursement Challenges + Potential for Digital Overload with Emerging DTx
Panel participants represent a wide spectrum of the emerging industry and will be announced in the months leading up to HLTH 2019.
*All registered HLTH attendees are welcome to attend the Evercore ISI panel sessions. Simply fill out the form to save your seat.
Use of Links